BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5214691)

  • 1. The role of the phagocyte in host-parasite interactions. 3. The phagocytic capabilities of leukocytes from myeloproliferative and other neoplastic disorders.
    Sbarra AJ; Shirley W; Selvaraj RJ; McRipley RJ; Rosenbaum E
    Cancer Res; 1965 Sep; 25(8):1199-206. PubMed ID: 5214691
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of the phagocyte in host-parasite interactions. V. Phagocytic and bactericidal activities of leukocytes from patients with different neoplastic disorders.
    McRipley RJ; Selvaraj RJ; Glovsky MM; Sbarra AJ
    Cancer Res; 1967 Apr; 27(4):674-85. PubMed ID: 4164931
    [No Abstract]   [Full Text] [Related]  

  • 3. [Infection resistance in hemoblastoses, functional studies on leukocyte mobilization in healthy and sick subjects].
    Senn H
    Exp Med Pathol Klin; 1972; 36():1-110. PubMed ID: 4559715
    [No Abstract]   [Full Text] [Related]  

  • 4. [Circulating immune complexes in patients with lymphoproliferative and myeloproliferative diseases].
    Loni C; Ricci S; Azzarà A; Bertoncini G
    Quad Sclavo Diagn; 1984 Jun; 20(2):193-202. PubMed ID: 6441963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on humoral and cellular immunity in leukemia and myelofibrosis].
    Patakfalvi A; Gógl A; Simon K; Böhm G; Miszlay Z; Kajtsa E
    Acta Med Acad Sci Hung; 1970; 27(3):307-19. PubMed ID: 5280019
    [No Abstract]   [Full Text] [Related]  

  • 6. [Quantitative immunoglobulin determination in leukemia and myelofibrosis].
    Horváth T; Patakfalvi A; Böhm G; Kajtsa E
    Haematologia (Budap); 1970; 4(3):319-26. PubMed ID: 5001991
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antibacterial immunity in hematopoietic proliferative diseases].
    Serafiŕska P; Lewicka T; Cassic J
    Acta Haematol Pol; 1973; 4(1):55-64. PubMed ID: 4522084
    [No Abstract]   [Full Text] [Related]  

  • 8. [Counting of leukocytes effective for the prevention of infection in leukemias by counting leukocytes in the saliva].
    Stobbe H; Zimmermann I; Strecker B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(3):347-52. PubMed ID: 4139054
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diagnostic and pathogenetic significance of some cytogenetic and cythochemical findings (leukocyte alkaline phosphatase) in systemic hemopathies with myeloproliferative tendencies].
    Cacciola E; Giustolisi R
    Haematologica; 1970; 55(5):311-32. PubMed ID: 4995787
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies of red cell isoantigens on peripheral leukocytes from normal and leukemic individuals.
    Kassulke JT; Hallgren HM; Yunis EJ
    Am J Pathol; 1969 Sep; 56(3):333-49. PubMed ID: 5258866
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of splenectomy on the phagocytic activity of neutrophils].
    Vinogradova IuE; Ivanina EK; Skriabin AS
    Ter Arkh; 1983; 55(8):68-71. PubMed ID: 6579696
    [No Abstract]   [Full Text] [Related]  

  • 12. The metabolic activities of leukocytes from lymphoproliferative and myeloproliferative disorders during phagocytosis.
    Selvaraj J; McRipley RJ; Sbarra AJ
    Cancer Res; 1967 Dec; 27(12):2287-94. PubMed ID: 5237348
    [No Abstract]   [Full Text] [Related]  

  • 13. [Disorder of the leukocytic defense function as a paraneoplastic syndrome in hemoblastoses].
    Senn HJ; Rhomberg WU; Jungi WF
    Schweiz Med Wochenschr; 1971 Apr; 101(13):466-70. PubMed ID: 5283772
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes in the immunity factors in patients with chronic leukemia].
    Podil'chak MD; Terletskaia LM; Podil'chak EM
    Vrach Delo; 1983 Jul; (7):50-3. PubMed ID: 6578635
    [No Abstract]   [Full Text] [Related]  

  • 15. [Quantification of granulocyte protection in hemoblastoses].
    Senn HJ; Jungi WF
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(3):337-46. PubMed ID: 4139053
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the cellular composition of sterile skin exudate in proliferative diseases of the hemopoietic system.
    Kowal E
    Pol Med J; 1969; 8(4):824-30. PubMed ID: 4936481
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the phagocytic activity of neutrophilic leukocytes.
    Brandt L
    Scand J Haematol Suppl; 1967; 2():1-126. PubMed ID: 5243720
    [No Abstract]   [Full Text] [Related]  

  • 18. Phagocytic activity of the leukemic cell and its response to the phagocytosis-stimulating tetrapeptide, tuftsin.
    Constantopoulos A; Likhite V; Crosby WH; Najjar VA
    Cancer Res; 1973 Jun; 33(6):1230-4. PubMed ID: 4124112
    [No Abstract]   [Full Text] [Related]  

  • 19. Reticuloendothelial phagocytic function in patients with leukemia, lymphoma and multiple myeloma.
    Groch GS; Perillie PE; Finch SC
    Blood; 1965 Oct; 26(4):489-99. PubMed ID: 5212597
    [No Abstract]   [Full Text] [Related]  

  • 20. [Phagocytic ability of blast cells in acute leukemia].
    Kaiser A
    Acta Haematol Pol; 1979; 10(1):46-50. PubMed ID: 285562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.